219 related articles for article (PubMed ID: 36361781)
21. A quantitative, single-cell PCR analysis of an antigen-specific TCR repertoire selected during an in vivo CD8 response: direct evidence for a wide range of clone sizes with uniform tissue distribution.
Maryanski JL; Attuil V; Bucher P; Walker PR
Mol Immunol; 1999 Aug; 36(11-12):745-53. PubMed ID: 10593513
[TBL] [Abstract][Full Text] [Related]
22. A rare population of tumor antigen-specific CD4
Matsuzaki J; Tsuji T; Chodon T; Ryan C; Koya RC; Odunsi K
J Immunother Cancer; 2019 Jan; 7(1):7. PubMed ID: 30626427
[TBL] [Abstract][Full Text] [Related]
23. CD28
Hashimoto H; Sterk M; Schilbach K
Immunol Res; 2018 Feb; 66(1):79-86. PubMed ID: 29138980
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4
Servaas NH; Zaaraoui-Boutahar F; Wichers CGK; Ottria A; Chouri E; Affandi AJ; Silva-Cardoso S; van der Kroef M; Carvalheiro T; van Wijk F; Radstake TRDJ; Andeweg AC; Pandit A
J Autoimmun; 2021 Feb; 117():102574. PubMed ID: 33307312
[TBL] [Abstract][Full Text] [Related]
25. Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis.
Aoki H; Shichino S; Matsushima K; Ueha S
Front Immunol; 2022; 13():807696. PubMed ID: 35154125
[TBL] [Abstract][Full Text] [Related]
26. Altered Repertoire Diversity and Disease-Associated Clonal Expansions Revealed by T Cell Receptor Immunosequencing in Ankylosing Spondylitis Patients.
Hanson AL; Nel HJ; Bradbury L; Phipps J; Thomas R; Lê Cao KA; Kenna TJ; Brown MA
Arthritis Rheumatol; 2020 Aug; 72(8):1289-1302. PubMed ID: 32162785
[TBL] [Abstract][Full Text] [Related]
27. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
28. Normal CD4 T-cell receptor repertoire in tonsillar tissue despite perturbed repertoire in peripheral blood in HIV-1 infected individuals.
Mugnaini EN; Syversen AM; Sannes M; Freng A; Brinchmann JE
AIDS; 1999 Dec; 13(18):2507-13. PubMed ID: 10630519
[TBL] [Abstract][Full Text] [Related]
29. Greater extent of blood-tumor TCR repertoire overlap is associated with favorable clinical responses to PD-1 blockade.
Aoki H; Ueha S; Nakamura Y; Shichino S; Nakajima H; Shimomura M; Sato A; Nakatsura T; Yoshino T; Matsushima K
Cancer Sci; 2021 Aug; 112(8):2993-3004. PubMed ID: 34014607
[TBL] [Abstract][Full Text] [Related]
30. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
[TBL] [Abstract][Full Text] [Related]
31. Limited T cell receptor repertoire diversity in tuberculosis patients correlates with clinical severity.
Luo W; Su J; Zhang XB; Yang Z; Zhou MQ; Jiang ZM; Hao PP; Liu SD; Wen Q; Jin Q; Ma L
PLoS One; 2012; 7(10):e48117. PubMed ID: 23110186
[TBL] [Abstract][Full Text] [Related]
32. T cell immune awakening in response to immunotherapy is age-dependent.
Salih Z; Banyard A; Tweedy J; Galvani E; Middlehurst P; Mills S; Weightman J; Gupta A; Lorigan PC; Zhou C; Dhomen N; Valpione S; Marais R
Eur J Cancer; 2022 Feb; 162():11-21. PubMed ID: 34952479
[TBL] [Abstract][Full Text] [Related]
33. Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies.
Cham J; Zhang L; Kwek S; Paciorek A; He T; Fong G; Oh DY; Fong L
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32376721
[TBL] [Abstract][Full Text] [Related]
34. TCR repertoire intratumor heterogeneity of CD4
Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
[TBL] [Abstract][Full Text] [Related]
35. Peripheral CD8
Fairfax BP; Taylor CA; Watson RA; Nassiri I; Danielli S; Fang H; Mahé EA; Cooper R; Woodcock V; Traill Z; Al-Mossawi MH; Knight JC; Klenerman P; Payne M; Middleton MR
Nat Med; 2020 Feb; 26(2):193-199. PubMed ID: 32042196
[TBL] [Abstract][Full Text] [Related]
36. Human T-cell memory consists mainly of unexpanded clones.
Klarenbeek PL; Tak PP; van Schaik BD; Zwinderman AH; Jakobs ME; Zhang Z; van Kampen AH; van Lier RA; Baas F; de Vries N
Immunol Lett; 2010 Sep; 133(1):42-8. PubMed ID: 20621124
[TBL] [Abstract][Full Text] [Related]
37. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
Pandolfino MC; Viret C; Gervois N; Guilloux Y; Davodeau F; Diez E; Jotereau F
Eur J Immunol; 1992 Jul; 22(7):1795-802. PubMed ID: 1623924
[TBL] [Abstract][Full Text] [Related]
38. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
Cole DJ; Weil DP; Shamamian P; Rivoltini L; Kawakami Y; Topalian S; Jennings C; Eliyahu S; Rosenberg SA; Nishimura MI
Cancer Res; 1994 Oct; 54(20):5265-8. PubMed ID: 7522957
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.
Kidman J; Principe N; Watson M; Lassmann T; Holt RA; Nowak AK; Lesterhuis WJ; Lake RA; Chee J
Front Immunol; 2020; 11():587014. PubMed ID: 33163002
[TBL] [Abstract][Full Text] [Related]
40. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]